COVID – 19 IgG & IgM

The investigation of COVID-19 relies significantly on the analysis of IgG and IgM antibodies. These antibodies, particularly IgM, swiftly emerge post-infection, signifying an initial immune response. Conversely, IgG antibodies form later but endure, offering prolonged immunity and indicating prior infection or vaccination. Examining both IgG and IgM aids in identifying infection stages and immunity, providing critical information about an individual’s COVID-19 status and potential resistance to future occurrences.